| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $99K | +0.0% |
| SG&A Expense | $1.3M | +96.5% |
| Operating Income | -$1.3M | -70.6% |
| Net Income | -$1.4M | -78.7% |
| EPS (Basic) | -$0.18 | -5.9% |
| EPS (Diluted) | -$0.18 | -5.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | -99.2% |
| Current Assets | $13K | -96.9% |
| Total Assets | $13K | -96.9% |
| Current Liabilities | $1.0M | +730.7% |
| Total Liabilities | $1.4M | +251.4% |
| Stockholders' Equity | -$1.4M | -4361.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$734K | -16.8% |
| Financing Cash Flow | $327K | -68.4% |